BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11976555)

  • 1. [Crystallochemistry of copper (II) and zinc (II) chelates by nonsteroidal antiinflammatory drugs].
    Viossat B; Morgant G; Sorenson JR; Roch-Arveiller M; Daran JC; Greenaway FT; Nguyen Huy D
    Ann Pharm Fr; 2002 Mar; 60(2):102-14. PubMed ID: 11976555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.
    Lemoine P; Viossat B; Dung NH; Tomas A; Morgant G; Greenaway FT; Sorenson JR
    J Inorg Biochem; 2004 Nov; 98(11):1734-49. PubMed ID: 15522401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-temperature (180 K) crystal structures of tetrakis-mu-(niflumato)di(aqua)dicopper(II) N,N-dimethylformamide and N,N-dimethylacetamide solvates, their EPR properties, and anticonvulsant activities of these and other ternary binuclear copper(II)niflumate complexes.
    Viossat B; Greenaway FT; Morgant G; Daran JC; Dung NH; Sorenson JR
    J Inorg Biochem; 2005 Feb; 99(2):355-67. PubMed ID: 15621267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-temperature crystal structures of tetrakis-mu-3,5-diisopropylsalicylatobis-dimethylformamidodico pper(II) and tetrakis-mu-3,5-diisopropylsalicylatobis-diethyletheratodicopp er(II) and their role in modulating polymorphonuclear leukocyte activity in overcoming seizures.
    Morgant G; Dung NH; Daran JC; Viossat B; Labouze X; Roch-Arveiller M; Greenaway FT; Cordes W; Sorenson JR
    J Inorg Biochem; 2000 Jul; 81(1-2):11-22. PubMed ID: 11001426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nickel(II), copper(II) and zinc(II) binding properties and cytotoxicity of tripodal, hexadentate tris(ethylenediamine)--analogue chelators.
    Ye N; Park G; Przyborowska AM; Sloan PE; Clifford T; Bauer CB; Broker GA; Rogers RD; Ma R; Torti SV; Brechbiel MW; Planalp RP
    Dalton Trans; 2004 May; (9):1304-11. PubMed ID: 15252622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid.
    Sylla-Iyarreta Veitía M; Dumas F; Morgant G; Sorenson JR; Frapart Y; Tomas A
    Biochimie; 2009 Oct; 91(10):1286-93. PubMed ID: 19563861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid and peptide bioconjugates of copper(II) and zinc(II) complexes with a modified N,N-bis(2-picolyl)amine ligand.
    Kirin SI; Dübon P; Weyhermüller T; Bill E; Metzler-Nolte N
    Inorg Chem; 2005 Jul; 44(15):5405-15. PubMed ID: 16022539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
    Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
    Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure and biomimetic properties of Cu(II)-Cu(II) and Cu(II)-Zn(II) binuclear complexes: possible models for the chemistry of Cu-Zn superoxide dismutase.
    Patel RN; Singh N; Shukla KK; Gundla VL; Chauhan UK
    J Inorg Biochem; 2005 Feb; 99(2):651-63. PubMed ID: 15621300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.
    Di Vaira M; Bazzicalupi C; Orioli P; Messori L; Bruni B; Zatta P
    Inorg Chem; 2004 Jun; 43(13):3795-7. PubMed ID: 15206857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic behavior of copper complexes of nonsteroidal anti-inflammatory drugs.
    Trinchero A; Bonora S; Tinti A; Fini G
    Biopolymers; 2004 May-Jun 5; 74(1-2):120-4. PubMed ID: 15137108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XAFS studies of anti-inflammatory dinuclear and mononuclear Zn(II) complexes of indomethacin.
    Zhou Q; Hambley TW; Kennedy BJ; Lay PA
    Inorg Chem; 2003 Dec; 42(25):8557-66. PubMed ID: 14658913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR spectroscopic characterization of copper(II) and zinc(II) complexes of indomethacin.
    Ramadan S; Hambley TW; Kennedy BJ; Lay PA
    Inorg Chem; 2004 May; 43(9):2943-6. PubMed ID: 15106982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin.
    Dillon CT; Hambley TW; Kennedy BJ; Lay PA; Zhou Q; Davies NM; Biffin JR; Regtop HL
    Chem Res Toxicol; 2003 Jan; 16(1):28-37. PubMed ID: 12693028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterization, antiradical and antidiabetic activities of copper(II) and zinc(II) Schiff base complexes derived from salicylaldehyde and beta-alanine.
    Vanco J; Marek J; Trávnícek Z; Racanská E; Muselík J; Svajlenová O
    J Inorg Biochem; 2008 Apr; 102(4):595-605. PubMed ID: 18037491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
    Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
    J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper and zinc binding properties of the N-terminal histidine-rich sequence of Haemophilus ducreyi Cu,Zn superoxide dismutase.
    Paksi Z; Jancsó A; Pacello F; Nagy N; Battistoni A; Gajda T
    J Inorg Biochem; 2008 Sep; 102(9):1700-10. PubMed ID: 18565588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, crystal structure, cytotoxic activity and DNA-binding properties of the copper (II) and zinc (II) complexes with 1-[3-(2-pyridyl)pyrazol-1-ylmethyl]naphthalene.
    Zhang H; Liu CS; Bu XH; Yang M
    J Inorg Biochem; 2005 May; 99(5):1119-25. PubMed ID: 15833335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.